We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Tool Predicts Patient Risk of Heart Procedures

By HospiMedica staff writers
Posted on 03 Aug 2001
A statistical model that will predict a heart patient's risk of death from coronary artery interventions such as balloon angioplasty or stenting has been developed by a team of eight hospitals coordinated by the University of Michigan Health System (UMHS). More...
The first study of the model was published in the July 2001 issue of Circulation.

The study showed that unlike previous estimates of such risk, based on general information, the new model allows doctors to customize risk assessment based on a patient's specific medical history. Using a standardized form, the researchers collected information on nearly 20,000 patients, including data on gender, age, medications taken, other medical conditions such as hypertension, and prior operations. Next, they scored the questions, giving points based on responses. The total was then compared to the statistical model, and patients were categorized into certain risk groups based on their score. Data on the processes of care are collected, the patients are followed, and their outcomes after coronary intervention are recorded.

The researchers emphasize that patient data should never be used to deny care but, rather, to give both the doctor and the patient more information on which to base a treatment decision. Patient data will also translate into improved safety for patients because doctors will be able to identify those at risk for certain complications and tailor treatment to diminish those risks. The collaborative effort has resulted in a much larger database and better pool of data than any one center could achieve on its own.

"The consortium is using the extensive database to identify best practices for coronary interventions, disseminate information about them, and foster quality and efficiency improvement among cardiovascular centers,” said Mauro Moscucci, M.D., UMHS director of interventional cardiology and the study's principal investigator.




Related Links:
Univ. of Michigan

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.